期刊
CNS NEUROSCIENCE & THERAPEUTICS
卷 27, 期 12, 页码 1437-1445出版社
WILEY
DOI: 10.1111/cns.13743
关键词
central nervous system diseases; exosome-based therapy; exosomes
资金
- National Institute of Neurological Disorders and Stroke [1R01NS102720]
- American Heart Association [18POST33990433]
Exosomes, secreted by various types of cells, play a crucial role in cell-to-cell communication by delivering proteins and nucleic acids. They are increasingly recognized for their involvement in the pathogenesis of central nervous system diseases and as a promising therapeutic strategy. Research has shown that exosome infusion has beneficial effects on CNS injury animal models, highlighting their potential in neurological medicine.
Exosomes (EXs), a type of extracellular vesicles, are secreted from virtually all types of cells. EXs serve as cell-to-cell communicators by conveying proteins and nucleic acids with regulatory functions. Increasing evidence shows that EXs are implicated in the pathogenesis of central nervous system (CNS) diseases. Moreover, EXs have recently been highlighted as a new promising therapeutic strategy for in vivo delivery of nucleotides and drugs. Studies have revealed that infusion of EXs elicits beneficial effects on the CNS injury animal models. As compared to cell-based therapy, EXs-based therapy for CNS diseases has unique advantages, opening a new path for neurological medicine. In this review, we summarized the current state of knowledge of EXs, the roles and applications of EXs as a viable pathological biomarker, and EX-based therapy for CNS diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据